Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03067779 · ClinicalTrials.gov registry record · NA

Is There a Digital Divide in Chronic Kidney Disease (CKD)?

A NA study of Chronic Kidney Disease, sponsored by Duke University.

Completed
Registry status
NA
Development phase
580
Enrollment target
4
Study locations

NCT03067779 is a NA study of Chronic Kidney Disease that has completed, run by Duke University. The registered enrollment target is 580 participants, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (82% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03067779, a NA study of Chronic Kidney Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
580 participants
Enrollment target
4
Study locations

Study Summary

This study is looking to improve the safety of patients with chronic kidney disease via education provided on a mobile tablet. This study will additionally examine if electronic tools, such as mobile tablets, can help.

Conditions Studied

Interventions

  • OTHER mHealth Tool

Study Locations (4)

Maryland

  • University of Maryland, Baltimore - Baltimore
  • Johns Hopkins University - Baltimore

North Carolina

  • Duke University School of Medicine - Durham

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 580 participants
Start Date 2017-06-26
Est. Completion 2018-07-30
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03067779

The ClinicalTrials.gov registry entry for NCT03067779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (82% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which mHealth Tool is the first listed.

NCT03067779 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Maryland, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03067779 about?

NCT03067779 is a clinical study titled "Is There a Digital Divide in Chronic Kidney Disease (CKD)?". This study is looking to improve the safety of patients with chronic kidney disease via education provided on a mobile tablet. This study will additionally examine if electronic tools, such as mobile tablets, can help.

What is the current status of trial NCT03067779?

This trial is currently completed. It is a NA study. The enrollment target is 580 participants. The study started on 2017-06-26. Estimated completion is 2018-07-30.

What conditions does trial NCT03067779 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT03067779?

The interventions under investigation include: mHealth Tool (OTHER).

Who is sponsoring clinical trial NCT03067779?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03067779 being conducted?

This trial has 4 study locations across Maryland, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.